Latest Myriad Genetics News & Updates

See the latest news and media coverage for Myriad. We track all announcements, press releases, and industry mentions in real time, all in one place.

Myriad Genetics (Myriad)

Genetic testing and genomic profiling company

myriad.com

Headquarters: Salt Lake City, United States
Founded year: 1991
Company type: Public company
Number of employees: 2,500–5,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Myriad Genetics (Myriad)

In short: Myriad reported an 11% revenue drop in Q2 2026, leading to a lowered full-year outlook and a significant decline in its stock price.

Company announcements

July 30 Myriad

Myriad Genetics reports second quarter 2026 financial results

Revenue fell 11% year-over-year to $190.7 million, with initiatives to improve efficiency and scalability.

July 23 Myriad

Myriad Genetics to release Q2 2026 financial results on July 30

The company will hold an earnings conference call at 4:30 pm ET on July 30 after market close, providing financial overview and business update.

July 9 Myriad

Myriad Genetics launches FirstGene Multiple Prenatal Screen

The test runs four prenatal genetic screens simultaneously from one blood draw as early as eight weeks gestation.

July 2 Myriad

Meta-analysis shows Myriad's Prolaris test predicts prostate cancer outcomes

Findings from 14 studies involving 8,478 patients support risk stratification beyond conventional clinical tools.

Media coverage

September 8 Yahoo Finance

Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks,...

September 2 The Globe and Mail

Stocks making big moves yesterday: Myriad Genetics, Greenbrier, Tidewater, Strategy, and Charter

Myriad Genetics (NASDAQ:MYGN): Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell by 6.2% on Tuesday after Piper ...

September 1 Yahoo Finance

Why Myriad Genetics (MYGN) Stock Is Down Today

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 6.2% in the afternoon session after Piper Sandler double-downgraded the stock to...

August 24 Yahoo Finance

Myriad Genetics and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled...

Never miss news about Myriad

Track Myriad and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Myriad competitors & trending companies

Browse news for competitors to Myriad and other trending companies.